Yonhap News Agency on MSN

SK Bioscience to speed up Ebola virus vaccine development with CEPI funding

SK bioscience Co., a biopharmaceutical arm of South Korea's SK Group, said Thursday it will accelerate the development of a ...
Contract Pharma

SK Bioscience to Support CEPI-Backed Development of Updated Zaire Ebolavirus Vaccine

SK Bioscience has joined a new international effort to advance an updated Zaire ebolavirus vaccine, following a funding agreement between the CEPI and Merck & Co.
The Manila Times

SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding

CEPI to provide up to USD 30 million to support development of MSD's Zaire ebolavirus vaccineCollaboration addresses ...

SK Bioscience speeds up Zaire Ebola vaccine development

SK Bioscience will accelerate the development of a next-generation Zaire Ebola vaccine with funding from the Coalition for ...
Science Africa on MSN

US$ 30M for more affordable Ebola vaccines

By Sharon AtienoA partnership between the Coalition for Epidemic Preparedness Innovations (CEPI) and Merck (MSD) is set to ...
News Medical

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single ...